The intended use is for determination of somatostatin in human plasma. Somatostatin in plasma is extracted with Sep-pak C18 cartridges. The extracts are analysed by a competitive radioimmunoassay using an antiserum to synthetic cyclic somatostatin 14. Somatostatin in standards and samples compete with 125I-labelled somatostatin in binding to the antibodies. 125I-Tyr1-somatostatin binds in a reverse proportion to the concentration of somatostatin in standards and samples. Antibody-bound 125I-Tyr1-somatostatin is separated from the unbound fraction using the double antibody solid phase precipitation technique. The radioactivity of the precipitates is measured.
| Catalog # | RB306RUO |
| Format | RIA |
| Label | I125 |
| Size | 100 tests |
| Sample Type | Plasma |
| Sample Volume | 1000 µL |
| Controls | 2 levels |
| Range | 3,9-125 pmol/L |
| Sensitivity | 6 pmol/L |
| Incubation | 20-24 hours |
| Shelf Life (weeks) | 12 |
Iodination Schedule 2015 :
Due to local registration requirement, this product can not be sold in Canada, United States, Australia – without prior registration.
For Japan and Brazil, specific registration requirements are necessary. For more information, please contact: RA@diasource.be.
| Download "Instructions for Use" | RB306RUO.pdf |  |
| Download "Material Safety Data Sheet" | MSRB306RUO.pdf | |
| Download brochure "Growth Factors" | CATR.pdf | |
| Download Calendar | CAL2020.pdf | |
News
Events
Newsletter